| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Firefly Neuroscience, Inc.: Firefly Neuroscience Reports 373% Year-Over-Year Increase in U18 ADHD Evoke"Scans as Commercial Expansion Accelerates | 1 | GlobeNewswire (USA) | ||
| 10.11. | FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln | |||||
| 27.10. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform | 3 | GlobeNewswire (USA) | ||
| 25.09. | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung | 10 | Investing.com Deutsch | ||
| 25.09. | Firefly Neuroscience, Inc.: Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD | 4 | GlobeNewswire (USA) | ||
| 17.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience's Evoke Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine | 1 | GlobeNewswire (USA) | ||
| 07.08. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | 522 | GlobeNewswire (Europe) | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| 28.07. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key Neuroprotective Peptides | 1 | GlobeNewswire (USA) | ||
| 22.06. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.06. | Firefly Neuroscience identifies PTSD biomarker using AI | 3 | Investing.com | ||
| 02.06. | Firefly Neuroscience, Inc.: Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD | 1 | GlobeNewswire (USA) | ||
| 26.03. | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | 855 | GlobeNewswire (Europe) | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| 13.03. | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | 694 | GlobeNewswire (Europe) | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 53,75 | -0,20 % | Fresenius verkauft weitere FMC-Aktien und reduziert Beteiligung auf 20 Prozent | Fresenius setzt den Rückzug aus seiner Beteiligung am Dialysespezialisten Fresenius Medical Care (FMC) fort. Der Gesundheitskonzern will rund 13,4 Millionen FMC-Aktien verkaufen, was etwa 5 Prozent... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,300 | -1,59 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Siemens Healthineers nach Zahlen zum vierten Geschäftsquartal 2025/26 von 39 auf 43 Euro angehoben, aber die Einstufung auf... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,870 | -3,88 % | EQS-News: Eckert & Ziegler SE: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler: Bereinigtes EBIT im dritten Quartal +25%. Prognose 2026 bestätigt
12.11.2026 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| UNITEDHEALTH | 352,60 | -0,45 % | UnitedHealth (UNH) vs. Humana (HUM): Buy the Dip? | ||
| TELADOC HEALTH | 7,612 | -1,40 % | Teladoc Health, Inc.: Teladoc Health Expands Comprehensive Weight Care Program with Employer Contribution Option for GLP-1 Medications | ||
| M1 AESTHETICS | 13,000 | -3,70 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| BECTON DICKINSON | 196,40 | +0,33 % | Becton, Dickinson And Company Q4 Profit Advances | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line totaled $696 million... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | +1,52 % | Sernova Biotherapeutics: 11,2 Millionen für die Fusion - BetaNova rückt näher | ||
| BOSTON SCIENTIFIC | 39,130 | +0,05 % | Boston Scientific ernennt neuen Lead Independent Director und aktualisiert Vergütungspläne | ||
| CERENOME | 0,649 | -10,48 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| INMODE | 11,770 | +0,30 % | InMode Ltd.: InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook | YOKNEAM, Israel, Nov. 11, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,730 | -0,57 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 15,900 | +2,58 % | Tandem Diabetes Care jumps 12% on FDA clearance for tubeless Mobi | ||
| CO-DIAGNOSTICS | 0,196 | 0,00 % | Co-Diagnostics receives test order from Peru amid dengue rise |